Vicarious Surgical (RBOT) Net Income towards Common Stockholders (QoQ) (2020 - 2025)
Vicarious Surgical (RBOT) Net Income towards Common Stockholders (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Vicarious Surgical | 625,212.51 | -9.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 16.32% |
| Jun 30, 2025 | 14.15% |
| Mar 31, 2025 | -10.54% |
| Dec 31, 2024 | 18.52% |
| Sep 30, 2024 | -12.40% |
| Jun 30, 2024 | 10.56% |
| Mar 31, 2024 | -29.67% |
| Dec 31, 2023 | 16.51% |
| Sep 30, 2023 | -2.41% |
| Jun 30, 2023 | 43.04% |
| Mar 31, 2023 | -140.81% |
| Dec 31, 2022 | 54.80% |
| Sep 30, 2022 | -1,602.48% |
| Jun 30, 2022 | -103.42% |
| Mar 31, 2022 | 95.20% |
| Dec 31, 2021 | 148.28% |
| Sep 30, 2021 | -579.78% |
| Jun 30, 2021 | -26.90% |
| Mar 31, 2021 | -38.24% |
| Dec 31, 2020 | -13.26% |